Cerebrovascular Diseases

 
Poor Adherence to Blood Pressure Rx Ups Risk of Stroke
July 20, 2013

Nonadherence to antihypertensive drug therapy increased risk of stroke, hospitalization for stroke and stroke-related mortality.

Pulmonary Embolism Presenting With Right Flank Pain
July 10, 2013

Pulmonary embolism was the diagnosis in these 3 women, each of whom presented with positional right flank pain.

Filling Gaps in Hypertension Rx: Sleep Disorders and Stroke
May 16, 2013

ASH 2013 has uncovered 2 glaring gaps in the management of people with sleep disorders (OSA as well as others) and appropriate care after a stroke. Both cohorts frequent primary care practice.

When the CHADS2 Score = 1: Will Aspirin Do or Is Warfarin Indicated?
May 16, 2013

The CHA2DS2-VASc score improves risk determination by incorporating age 65 to 74 years, female sex, and history of vascular disease.

Predict Midlife Cognitive Decline With Heart Disease Risk Scores
April 11, 2013

Heart disease and stroke risk prediction tools may be more useful in predicting cognitive decline in middle-aged patients than a dementia risk test, according to a new study.

First Stroke Risk Reduced With High Fiber Intake
April 10, 2013

Persons who eat a high-fiber diet experience a lower risk of first-time stroke, according to a new meta-analysis that supports current guidelines to increase fiber consumption.

Interruption of Rivaroxaban vs Warfarin for AF: A Comparison of Risk
April 09, 2013

Interruption of anticoagulation with rivaroxaban or warfarin should be bridged with an agent such as low-molecular weight heparin.

Stroke at Young Age Ups Risk for Death
March 23, 2013

Depending on the specific type of event, stroke at age 50 years or younger increased mortality at least 3-fold.

Sleep Apnea Doubles Risk for Stroke Precursor in Elderly
March 16, 2013

Sleep apnea in adults aged 65 years or older posed an increased risk for silent cerebral infarction and lacunar infarction.

Residual Cardiovascular Risks: Don’t Forget Kidney and Vascular Disease
February 28, 2013

Typical interventions in persons without CKD are essential. SHARP and TNT have added to our knowledge. Aggressive cholesterol lowering (probably also affecting LDL particle number as well as traditional measures of LDL) seems to afford better outcomes by lessening residual risk in those with chronic kidney disease.